Matt, Author at European Medical Journal - Page 70 of 212

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S…

Rheumatology in Cyprus amid the COVID-19 pandemic

In March 2020, the COVID-19 pandemic arrived in Cyprus. Suddenly, our lives and our way of life has been affected in an unprecedented way…

parking image

GMB Calls for the Extension of Free Parking for NHS Staff Indefinitely

GMB, the Union for NHS staff, has called for the indefinite extension of the UK governments scheme to suspend NHS staff parking…

National Rosacea Society Reveals New Guidelines on Standard Treatment Options for Rosacea

National Rosacea Society Reveals New Guidelines on Standard Treatment Options for Rosacea

GUIDELINES for the standard treatment options of rosacea, including recommendations for oral therapies, topical therapies, and light-based devices…

New At-Risk Group Identified for Early Melanoma Diagnosis and Treatment

New At-Risk Group Identified for Early Melanoma Diagnosis and Treatment

EVERY YEAR, 197,000 melanoma diagnoses are made globally, and in the UK alone the malignancy constitutes approximately 5% of cancer cases…

The People Versus COVID-19

DOMINATING headlines since January has been coronavirus and its global spread. Geographical knowledge has been sharpened by daily maps bleeding red…

EMJ 5.1

Preparing Patients for Intervention: Interviews with Key Opinion Leaders in Hepatology and Interventional Radiology

For this article, EMJ conducted interviews with two key opinion leaders, Prof Edoardo G. Giannini and Dr Sachin Modi, world experts in hepatology…

Editor's Pick: Chronic Spontaneous Urticaria: A Review of Pathological Mechanisms, Diagnosis, Clinical Management, and Treatment

Urticaria is a common mast cell-driven disease characterised by wheals and/or angioedema (), defined as chronic…

EMJ 5.1

Pulmonary Rehabilitation is Improved by In-Shoe Foot Orthosis Intervention

Pulmonary rehabilitation (PR) is currently the most cost-effective approach designed to improve exercise tolerance, peripheral muscle function…

EMJ 5.1

Epigenetics of Diabetic Nephropathy: From Biology to Therapeutics

Diabetic nephropathy (DN) is one of the major microvascular complications associated with diabetes in terms of increased healthcare costs…